These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 6236748

  • 1. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
    Gay JD, DeYoung DR, Roberts GD.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):94-6. PubMed ID: 6236748
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
    Fenlon CH, Cynamon MH.
    Antimicrob Agents Chemother; 1986 Mar; 29(3):386-8. PubMed ID: 2940969
    [Abstract] [Full Text] [Related]

  • 3. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
    Young LS, Berlin OG, Inderlied CB.
    Am J Med; 1987 Apr 27; 82(4A):23-6. PubMed ID: 3107379
    [Abstract] [Full Text] [Related]

  • 4. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL, van der Ros-van de Repe J, van Veldhuizen G.
    Antimicrob Agents Chemother; 1983 Aug 27; 24(2):302-4. PubMed ID: 6227281
    [Abstract] [Full Text] [Related]

  • 5. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
    Barry AL, Jones RN, Thornsberry C, Ayers LW, Gerlach EH, Sommers HM.
    Antimicrob Agents Chemother; 1984 May 27; 25(5):633-7. PubMed ID: 6233935
    [Abstract] [Full Text] [Related]

  • 6. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S, Sparham PD, Spencer RC.
    J Antimicrob Chemother; 1987 May 27; 19(5):605-9. PubMed ID: 3112094
    [Abstract] [Full Text] [Related]

  • 7. In-vitro susceptibility of mycobacteria to ciprofloxacin.
    Collins CH, Uttley AH.
    J Antimicrob Chemother; 1985 Nov 27; 16(5):575-80. PubMed ID: 2934361
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J, Mormède M, Fourche J, Bébéar C.
    Eur J Clin Microbiol; 1987 Oct 27; 6(5):584-6. PubMed ID: 3125050
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of ciprofloxacin (Bay o 9867).
    Fass RJ.
    Antimicrob Agents Chemother; 1983 Oct 27; 24(4):568-74. PubMed ID: 6228192
    [Abstract] [Full Text] [Related]

  • 10. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
    King A, Shannon K, Phillips I.
    J Antimicrob Chemother; 1984 Apr 27; 13(4):325-31. PubMed ID: 6233249
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of ciprofloxacin and norfloxacin against Gardnerella vaginalis.
    Machka K.
    Eur J Clin Microbiol; 1984 Aug 27; 3(4):374. PubMed ID: 6237906
    [No Abstract] [Full Text] [Related]

  • 12. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Molina-Torres CA, Ocampo-Candiani J, Rendón A, Pucci MJ, Vera-Cabrera L.
    Antimicrob Agents Chemother; 2010 May 27; 54(5):2188-90. PubMed ID: 20231398
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A, Petermüller C.
    Eur J Clin Microbiol; 1983 Apr 27; 2(2):111-5. PubMed ID: 6222896
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.
    Heessen FW, Muytjens HL.
    Antimicrob Agents Chemother; 1984 Jan 27; 25(1):123-4. PubMed ID: 6230988
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.
    Diez-Enciso M, Mas-Jimenez G, Velasco-Cerrudo A, Gutierrez-Altes A.
    Eur J Clin Microbiol; 1984 Aug 27; 3(4):367. PubMed ID: 6237905
    [No Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M, Rodriguez F, Villalba R, Benavente MC, Gonzalez AI.
    Chemioterapia; 1987 Dec 27; 6(6):431-3. PubMed ID: 3481302
    [Abstract] [Full Text] [Related]

  • 17. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov 27; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 18. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
    Chin NX, Neu HC.
    Antimicrob Agents Chemother; 1984 Mar 27; 25(3):319-26. PubMed ID: 6232895
    [Abstract] [Full Text] [Related]

  • 19. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
    Foroumadi A, Soltani F, Moshafi MH.
    Boll Chim Farm; 2002 Mar 27; 141(5):394-6. PubMed ID: 12481384
    [Abstract] [Full Text] [Related]

  • 20. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ, Mallet MN, Gulian C, Terriou P, Lagier P, de Micco P.
    Pathol Biol (Paris); 1988 May 27; 36(5):477-81. PubMed ID: 3136429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.